Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4540_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
88
CHAP TER3 Thehead
Investigation
A CT scan should be per formed as soon as possible after the bleed. Delay in performing the scan reduces its diagnostic rate as the blood lyses. Anormal C T scan does not r ule out a SAH. LP and CSF spectro­photometr y for bilirubin is required in all suspected cases if the CT scan is normal, but if performed too soon, the CSF can be normal, as bilirubin has not yet been produced from the blood breakdown products. The LP should not therefore be performed within 12 hour s from the onset of headache.
Once SAH has been diagnosed, CT angiography or cerebral catheter angi­ography is performed to determine the cause (Figure3.9).
Often CT angiography is per formed as the rst- linetest.
Management
Resuscitation, IV uids, routine bloods including clotting studies.
Analgesics, antiemetics.
Oral nimodipine. This improves outcome by reducing the risk
of ischaemic complications. It limits the normal surrounding
vasoconstrictor response that occurs following ableed.
Aneur ysms are secured by either surgical clipping or endovascular
embolization. In many centres, practice has moved towards
endovascular coiling as the mainstay of aneurysm treatment.
AVMs can be excised, embolized, or treated with extremely high-
dose, nely localized radiation (stereotactic radiosurgery), which
leads to gradual obliteration over a 2- year period.
If no structural cause is found on detailed angiogr aphy, the patient
can be reassured that they are not at increased risk of further bleeds.
Figure3.9 Angiogram showing berry aneurysm.
INTRACRANIAL BLEEDING (NON-TRAUMATIC)
The prognosis for recovery from a SAH is closely associated with the GCS. A lower GCS will likely result in a worse outcome.
ComplicationsofSAH
Vasospasm— this results in stroke/ death in 15% of patients with
SAH. At day 7, up to 70% will have angiographic vasospasm, although this is only clinically manifest in 20 – 30% . The pathophysiology is poorly understood but the risk is increased with a heav y blood load. In patients who develop vasospasm, hypertensive therapy is often instituted when the aneur ysm is secured. This involves transfer to level 3 care and an inotrope infusion. Direct angioplasty by intra­arterial nimodipine can also betried.
Hydrocephalus occur s in 25% of patients. This is often
communicating and can usually be managed with LPs or an external ventr icular drain. Ashunt may be required.
Seizures have been repor ted in 5– 10% of SAH patients.
Electrolyte problems— this is usually low sodium and of ten due
to ‘cerebral salt wasting’. It is treated with adding sodium orally or intravenously using 1.8% saline. Fluid restriction is dangerous as it may precipit ate vasospasm.
ECG/ cardiac rhythm changes occur in >50% of SAH patients.
Pulmonary oedema and pneumonia are common.
eSpontaneous intracerebral haemorrhage
ICH, a form of stroke, is most commonly due to hyper tension. Bleeding disorders, AVMs, aneurysms, tumours, and venous hypertension sec­ondary to central venous thrombosis can also be responsible.
Clinical features
These include the following, but not all need to be present:
Headache
Loss of consciousness
Focal neurological decit.
Investigation/ management
Resuscitation, IV uids, clotting studies.
CT scan. This should be performed as soon as possible after the
onset of symptoms, especially if the patient is unconscious or an aneurysmal SAH is a possibility.
An LP is unnecessary and potentially dangerous.
An angiogram should be considered, especially if the clot is close
to the circle of Willis or Sylvian ssure (possible aneurysmal cause) in younger non- hyper tensive patients (possible AVM), or if surgical evacuation is being considered.
Neurosurgeons may consider ICH evacuation if the patient is
deteriorating due to raised ICP and the clot is supercial.
Stroke rehabilitation. This will be necessary in the majority of
patients.
89
90
CHAP TER3 Thehead
eHydrocephalus and raised intracranial pressure
eHydrocephalus
Communicating:there is free ow of CSF from the ventricular system
to the subarachnoidspace.
Non- communicating (or obstructive):there is an obstruction within
the ventricular system so that the CSF cannot reach the subarachnoid
space. It is not safe to perform a LP in thisgroup.
Clinical features
Headache
Vomiting
Visual disturbance/loss of upgaze
Deterioration in consciousness.
Investigations
A CT scan will t ypically show ventricular dilatation. The four th ventricle is usually dilated in communicating hydrocephalus, but may be small in non- communicating hydrocephalus. AMRI scan might be necessar y, par­ticularly if a third ventriculostomy is being considered, to visualize the basal cisterns.
Management
Shunts:divert CSF into the peritoneum, or less commonly the right
atrium or pleura.
Third ventriculostomy:creates an internal bypass by forming a stoma
between the oor of the third ventricle and the basal cisterns.
External ventricular drainage:the CSF drains via a manometer to
an external collecting system. This is usually per formed if there is
infection or bloodstained CSF preventing shunt insertion, or in an
emer genc y when there is insucient time to insert ashunt.
eRaised intracranial pressure (intracranial hypertension)
Causes include:
Ma sses (tumour, infarction with oedema, contusions, haematoma, or
abscesses)
Generalized swelling (ischaemia, acute liver failure, hypertensive
encephalopathy, hypercarbia, and Reye’s syndrome)
Increase in venous pressure (venous sinus thrombosis, heart failure,
or mediastinal obstruction)
Obstructed CSF (aqueduct stenosis, Chiari malformation, meningeal
disease)
Increased CSF production (choroid plexus tumour)
Craniosynostosis
Idiopathic
Management is directed at the cause. CSF diversion may be required.
SHUNTS AND SHUNT COMPLICATIONS
eShunts and shunt complications
These are devices used in the management of hydrocephalus. T hey divert CSF into the peritoneum (or less commonly the right atrium or pleura) and maintain the ICP at the correct level. If a shunt fails to function cor­rectly the ICP is aected. Total obstruction can result in r apid onset of symptoms and deterior ation in consciousness. Shunt s consistof:
Aventricular catheter.
Asubcutaneous reservoir— for samplingCSF.
Avalve— this may have an incorporated reservoir, depending upon
thetype.
Adistal catheter— most commonly to the peritoneum
(ventriculoperitoneal (VP) shunt), but occasionally to the right atrium via the internal jugular vein (ventriculoatrial (VA) shunt) or pleura.
Shunt assessment
CT scan:to look at the ventricular size. It is most useful to compare
the scan with a previous scan taken when the shunt was known to be functioning.
However, in patients who have had multiple- shunt revisions, the
ventr icular wall can become sti and the ventricles may not dilate.
Shunt series:plain X- rays of the whole of the shunt to look for
breakages, disconnections, or migration of the shunt from it s usual location.
Shunt tap:a needle is inserted into the subcut aneous reservoir
under aseptic technique. This can exclude infection, reduce ICP by removing CSF, and also assess ventricular catheter patency.
eShunt obstruction
The commonest site of a blocked shunt is the ventricular catheter (due to choroid plexus), followed by the valve (due to CSF debris) and the distal catheter (due to omentum in VP shunts and clot in VA shunts). Ablocked shunt usually presents with similar symptoms to the patient’s initial pre­sentation, but the symptoms of ten progress more rapidly.
CT scan usually conrms the diagnosis but if there is doubt , symptom-
atic patient s should be admitted for observation until their symptoms have settled. If symptoms persist, the obstructed component, or the whole shunt , will need to be replaced. Attempts to clear the obstruction usuallyfail.
eShunt infection
Shunt infections usually develop within a few week s of the last shunt operation and are due to contamination from skin bacter ia. Patients can present with symptoms of a blocked shunt accompanied by a fever. They usually do not have meningism. An infected VA shunt will usually not block and so the infection may continue undetected for a long period.
The symptoms of an infected VA shunt usually consist of vague ill
health and a low- grade temperature. Diagnosis is by a shunt tap, with CSF microscopy and culture. The CSF WCC might be normal, as CSF ow ushes the bacteria away from the ventricles. Antibiotics alone are
91
92
CHAP TER3 Thehead
usually insucient to clear a shunt infection. Removal of the shunt and external ventr icular drainage are often necessary, with a new shunt being inserted when the CSF is sterile.
Prophylactic antibiotics have not been shown to prevent shunt infec­tions. New antibiotic impregnated or silver-lined shunt catheters are available.
eShunt overdrainage
Occasionally a shunt will drain excessive CSF, so that the patient devel­ops low- pressure headaches, which are worse when upright and are eased by lying down. If the ventricles are very large, the low pressure can cause them to collapse, tearing cor tical bridging veins and causing subdural haematomas. These patients can have symptoms of raised ICP with a hemiparesis.
Low- pressure headaches are treated with reassurance and advising a high uid intake. Caeine can also be helpful. The shunt can be revised if the symptoms persist.
eIntracranial thrombosis
eVenous sinus thrombosis
Venous sinus thrombosis can aect any age and either sex, but most commonly aects young and middle- aged females. It can be caused by trauma with depressed fractures overlying the sinus, tumours invading the sinus, and post neurosurgery.
Clinical features
Headaches, especially in the morning
Visual disturbance
Papilloedema.
Investigations
CT or MRI scans might show brain swelling. The ‘delta’ sign is a triangular lling defect in the sinus on a contrast CT scan. An occluded sinus is usually visible on MRI scans. Infarc tion or haemorrhage due to venous hyper tension might also be visible.
Management
Anticoagulation.
Thrombolytic therapy may be given if the patient is deteriorating.
CSF diversion:may be necessary later if intracranial hypertension
results.
eCavernous sinus thrombosis
Often fatal in the pre- antibiotic era, cavernous sinus thrombosis is essentially a septic thrombosis within the cavernous sinus. It usually arises from an infection in the face (hence the advice not to squeeze spots!), most commonly the periorbital region, but it can also arise from parana sal sinus infection.
Propagation of an infected thrombus to the cavernous sinus occurs against venous ow, because of the absence of valves in the facial,
CEREBRAL TUMOURS
angular, ophthalmic, and pterygoid plexus of veins. Thrombosis might spread to other venous sinuses and the infection may spread to cause subdural empyema or meningitis. Infective endocarditis and thrombosis of the internal carotid artery can alsooccur.
Clinical features
Systemic upset:swinging pyrexia/ tachycardia/ rigors/ sweats.
Facial or periorbitalpain.
Venous obstruction:eyelid oedema/ dilated facialveins.
‘Pulsating exophthalmos’:a transmitted carotid pulse with periorbital
oedema.
Blindness with papilloedema and retinal haemorrhages.
Ophthalmoplegia:classically CN VI rst followed by CNs III andIV.
Obvious site of infection:usually unilateral initially; most commonly a
periorbital cellulitis.
Central signs:developing evidence of meningeal irritation.
Bilateral signs develop with contralateral extension of thrombus.
Investigations
CT or MRI scans:usually show br ain swelling and possible local
infection. An occluded sinus might be visible on MRIscans.
Bloods including inammatory markers and coagulation studies.
Cerebral angiogram, with venous phase (if diagnosis uncertain).
Investigations into the cause of the infection.
Management
Antibiotics and drainage of any collection ofpus.
Anticoagulation.
Thrombolytic therapy might be considered if the patient is
deteriorating.
cCerebral tumours
There are a large number of dierent brain tumour s and cysts, both benign and malignant. Commonly they present with one of three syn­dromes (or a combination ofthem):
RaisedICP
Progressive neurological decit
Epilepticts.
Investigations
MRI scan is now the investigation of choice and will invariably be required before surgery, but a CT scan, without and with contrast, is usually the rst- line investigation. Malignant tumours are seen as irregular enhanc­ing lesions that might be cystic or solid, with mass eect and surrounding oedema. The three commonest tumoursare:
Metastases, which can be small, round ‘cannon ball’ lesions, usually
multiple, at the grey– white mater junction and most commonly in the middle cerebral artery terr itory; if suspicious, a CT chest/ abdomen/ pelvis can be performed to search for a primary source.
93
94
CHAP TER3 Thehead
Gliomas, which are usually large irregular lesions with indistinct
margins.
Meningiomas, which have a dural at tachment and homogeneous
contrast enhancement.
Management
Steroids to reduce vasogenic oedema— t ypically dexametha sone
4 mg four timesdaily. This is usually given with a proton pump
inhibitor for gastric protection.
Anticonvulsants should be given if the patient has had ts. Some
neurosurgeons use prophylactic anticonvulsants.
Neurosurgical referral. Excision of the tumour is the preferred
treatment, but might not be possible due to the site of the tumour,
the extent or nature of the lesion, or the frailty of the patient, in
which case a biopsy or debulking may be per for med or a palliative
course of management without surgery.
In high- gr ade malignant tumours, patients will proceed to adjuvant therapy with radiotherapy with or without chemotherapy. There are advances in this eld based on molecular proling of tumours.
Emergency treatment
Rarely, if the patient is deterior ating rapidly, IV mannitol and a ma ssive dose of dexamethasone should be given pending neurosurgical transfer and emergency surgery.
eExtracranial causes ofheadache
eTemporal arteritis
Temporal arteritis (giant cell arteritis) is a vasculitic disease predomi­nantly aecting patients over 60years of age. It is an important diagnosis in the elderly patient who presents with severe headache because of the potential for blindness if left untreated.
Clinical features
Patients present with a headache that is either a generalized ‘tension’ type or severe and well localized over the temporal arteries, often with burning or tenderness of the scalp. Jaw claudication on chewing can be another feature, thought to be due to involvement of the facial artery. There may also be weight loss, arthralgia, andfever.
Of great importance is the risk of sudden ir reversible loss of sight which may occur within weeks of the onset of symptoms. Often the pre­senting feature is of a visual eld disturbance, which becomes progres­sively worse. Blindness is thought to occur as a result of ischaemic optic neuritis caused by arteritis of the ophthalmic arteries.
Temporal arteritis generally aects medium and large sized ar teries. Branches of the carotid arteries are the commonest sites of involvement, but the vertebr al, meningeal, and intr acerebral vessels can be involved leading to hemiplegia or epilepsy.
EXTRACRANIAL CAUSES OF HEADACHE
Investigations
ES R is usually markedly raised in excess of 90mm/ hour in these
patients.
Temporal ar tery biopsy will help to conrm the diagnosis. However,
the disease gener ally shows ‘sk ip lesions’ and therefore a negative biopsy does not exclude a diagnosis.
Management
The aims of management are to reduce the pain and prevent compli­cations, particular ly blindness. High- dose steroids are given urgently. Dosage can be titrated against the ESR, and clinical response, but it may be necessary to continue treatment for 2– 3years with a gradually reducingdose.
cPolymyalgia rheumatica
Polymyalgia rheumatica (PMR) is a condition of middle- aged/ elderly patients which is associated with temporal/ giant cell arteritis. It is characterizedby
Systemic upset— weight loss, fever, fatigue.
Severe arthralgia with stiness— usually bilateral and symmetrical.
ElevatedESR.
Arapid response to small doses of cor ticosteroids.
Around 50% of patients with temporal arteritis have symptoms of PMR, whereas 15– 50% of patients with PMR have giant cell arteritis.
Glaucoma
(See E Chapter 10, pp. 303–5.) Patients may complain of pain in and around the eyes. It is impor tant to consider ophthalmic conditions, espe­cially glaucoma.
cFrontal sinusitis
This is potentially serious due to the r isk of intracranial infection. The front al sinuses make up one of the four paranasal sinuses. They are formed by extension of the ethmoidal air cells, into which they drain. These sinuses are absent at birth, but become reasonably well devel­oped by the age of 7, reaching their full size after pubert y. In up to 4% of the population they can be absent . The right and left sinuses form a cav­ity within the frontal bone, which is highly variable in size and shape and rarely symmetrical. A midline septum separates the two. The aver age sinus volume is approximately 6 – 8mL.
Each sinus is lined with ciliated mucus- secreting epithelium. Mucus
drains into the middle meatus of the nose via the frontonasal ducts (or front al sinus drainage pathways (FSDP)). The ducts pass through the ethmoid sinuses taking a variable pathway. (This is an important point to remember when managing apparently isolated NOE fr actures. It is around the drainage of the front al sinus that classication, management, and complications of these injuries are based.)
If free drainage of mucus from the frontal sinus is impaired, infection
can occur, resulting in frontal sinusitis. Patients complain of frontal head­ache, which is tender to percussion. Untreated, the infection can spread intracranially or spread into the orbit (orbital cellulitis).
95
96
CHAP TER3 Thehead
cEthmoid sinusitis
This usually occurs with other sinus infections. Patients complain of deep- seated throbbing pain, deep to the bridge of the nose. The medial orbital walls are paper thin, so orbital cellulitis can rapidly develop.
Clinical presentation offrontal/ ethmoid sinusitis
Headache/ facialpain.
Sensation of dull, constant pressure over the aectedsinus.
Symptoms are usually localized over the involved sinus and are of ten
made worse on bending, straining, or lyingdown.
Nasal discharge.
Halitosis.
Post- nasaldr ip.
Pott’s puy tumour is a rare clinical entit y char acterized by
subperiosteal abscess associated with osteomyelitis. It is usually seen
as a complication of frontal sinusitis or trauma predominantly in the
adolescent agegroup.
Management ofsinusitis
Antibiotics and in some cases, sinus washout with opening of the mid­dle meatus, using functional endoscopic sinus surger y. Ephedrine nasal drops and menthol inhalations may help reduce congestion and improve sinus drainage.
bDrug/ medication- induced headache
Many dr ugs can cause headaches among their side eects. Caeine can result in severe pain sometimes on waking. Migraine suerers are particularly vulnerable to a vicious c ycle of pain requiring increasing medication, which then trig gers more pain. Medication should be slowly withdrawn. In some cases prednisone may help control pain during this period.
bIce- cream headache
Some patients are prone to develop sudden, sharp head pain within a few seconds of eating or drinking anything cold, which stimulates the palate. The pain usually lasts less than a minute and resolves completely. It is believed to result from either rapid constriction and swelling of the anterior cerebr al ar teries, or as a result of referred pain from the roof of the mouth to the head. Treatment is preventative measures (eat slowly).
bPrimary sexual headache (coital cephalalgia)
In this condition, the pattern of headaches can be variable. Some appear suddenly and stop abruptly; other s occur on a regular basis for a long period of time. Attacks may be mild or severe. The dierential diagnosis is SAH as this has been precipitated by coitus in patients. Management includes avoiding/ reducing activities which precipitate symptoms. Propranolol, indometacin, and calcium- channel blockers (e.g. diltiazem) mayhelp.
Remember that carbon monoxide poisoning can also present with a headache.
PRIMARY HEADACHES
bPrimary headaches
These are not emergency conditions but are included as they are within the dierential diagnosis of headache.
bMigraine
Migraine is a severe headache that may present as a facial pain aecting the cheek, orbit, or forehead. However, classical migraine with preced­ing visual distur bances and an aura rarely aects theface.
‘Common’ migraine is ten times more frequent and is described as a
severe pulsatile headache invariably associated with nausea. Migraine is episodic in nature and is thought to aect approximately 10% of the population. It is more common in females (3:1), usually begins around puberty and continues into middle age, and there may also be a family history.
Classic migraine is described a s starting with an impending sense of
ill health and a visual aura (e.g. ashing lights). The throbbing, severe, sharp unilateral headache is associated with anorexia, nausea and vomiting, photophobia. and withdrawal— the patient often wants to just go into a darkened room andsleep.
Associations have been made with such trigger factors a s stress, diet (chocolate, cheese, red wine), hormonal state (pre- menstr ual, oral con­traceptive pill), emotions (anger, excitement), and barometric changes.
Some migraines can cause temporary hemiparesis (hemiplegic migraine) or
hemisensory loss. This can result in diagnostic confusion.
Management
Recognizing and removing precipitating causes, and simple analgesics in the rst instance. Antiemetics may also be used to reduce nausea. If attacks are frequent and aect routine daily ac tivities then prophylactic treatment can be considered with, e.g. oral pizotifen at night, or daily beta- blockers. In severe cases, patients may be prescribed sumatriptan to use in the prodrome state. Avoid narcotics.
bCluster headaches
Attacks generally occur in clusters, usually at night for 1– 3 weeks, every 12– 18 months. More common in men bet ween 20 and 40years it may be precipitated by alcohol. Typically the patient is woken at night by a severe unilateral stabbing or burning pain which may be frontal temporal, around the eye or over the cheek. Nausea is not a common feature but there is frequently rhinor rhoea, unilateral nasal obstr uction, and the eye may be red (conjunctival injection) with lacrimation.
Cluster headaches often respond to ergotamine. Other prescribed
drugs include verapamil, topiramate, and lithium.
bTension headaches
Tension headaches are described as a feeling of pressure, or a ‘band­like’ tightness that varies in intensity, frequency, and duration. It is often felt bilaterally over the forehead or temples but may aect the vertex, occiput, or eyes. Commonest in middle- aged women with a ssociated stress or depression, it may be chronic or episodic and is only occasion­ally helped with simple analgesics (NSAIDs).
97